Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $211000.0.

  • Vivos Therapeutics' Other Non-Current Assets fell 2355.07% to $211000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $211000.0, marking a year-over-year decrease of 2355.07%. This contributed to the annual value of $216000.0 for FY2024, which is 2964.17% down from last year.
  • According to the latest figures from Q3 2025, Vivos Therapeutics' Other Non-Current Assets is $211000.0, which was down 2355.07% from $255000.0 recorded in Q2 2025.
  • In the past 5 years, Vivos Therapeutics' Other Non-Current Assets registered a high of $374648.0 during Q2 2021, and its lowest value of $211000.0 during Q3 2025.
  • Moreover, its 5-year median value for Other Non-Current Assets was $308000.0 (2023), whereas its average is $311431.3.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 1521.04% in 2021, then plummeted by 3019.48% in 2025.
  • Over the past 5 years, Vivos Therapeutics' Other Non-Current Assets (Quarter) stood at $356000.0 in 2021, then increased by 5.06% to $374000.0 in 2022, then dropped by 17.91% to $307000.0 in 2023, then decreased by 29.64% to $216000.0 in 2024, then decreased by 2.31% to $211000.0 in 2025.
  • Its Other Non-Current Assets was $211000.0 in Q3 2025, compared to $255000.0 in Q2 2025 and $215000.0 in Q1 2025.